Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Behind the Bill

Blog
08/07/2024
Supreme Court overturns Chevron: what it means for FDA power, drug laws, and public health.
Supreme Court overturns Chevron: what it means for FDA power, drug laws, and public health.
Supreme Court overturns Chevron:...
08/07/2024
First Report Managed Care
Blog
07/31/2024
With 300 active drug shortages, several industry stakeholders have proposed plans to enhance supply chain resilience.
With 300 active drug shortages, several industry stakeholders have proposed plans to enhance supply chain resilience.
With 300 active drug shortages,...
07/31/2024
First Report Managed Care
Blog
07/24/2024
The M3P offers financial relief by spreading payment throughout the year, and CMS’ latest guidance clarifies key outreach parameters.
The M3P offers financial relief by spreading payment throughout the year, and CMS’ latest guidance clarifies key outreach parameters.
The M3P offers financial relief...
07/24/2024
First Report Managed Care
FY2025
Blog
07/17/2024
FY 2025 planning shows potential budget cuts for HHS and FDA, which could limit their ability to enforce regulations and address key issues.
FY 2025 planning shows potential budget cuts for HHS and FDA, which could limit their ability to enforce regulations and address key issues.
FY 2025 planning shows potential...
07/17/2024
First Report Managed Care
Blog
07/10/2024
In the first installment of Behind the Bill, we look at the potential industry effects of the Chevron doctrine overturn and the Corner Post ruling.
In the first installment of Behind the Bill, we look at the potential industry effects of the Chevron doctrine overturn and the Corner Post ruling.
In the first installment of...
07/10/2024
First Report Managed Care

Advertisement

Advertisement

Advertisement